Market access and reimbursement in Canada – changes at CADTH
What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health (CADTH) in 2024/2025? In this webinar, Clare Foy (Director – Global Market Access, Mtech Access) interviewed Don Husereau (Adjunct Professor of Medicine, The University of Ottawa). We take a look at the market access, health policy, and health technology assessment in Canada. Clare Foy and Don Husereau explore: Th...